jp morgan glp-1 Drug Market: the rapid growth of the diabetes and obesity drugs market Obesity Drug Market to Reach
Description
Starting at a low dose and titrating slowly allows your body to adapt and helps distinguish between expected GLP-1 side effects and genuine medication intolerance
[DOI] [PubMed] [Google Scholar] 317.Jorsal T., Rhee N.A., Pedersen J., Wahlgren C.D., Mortensen B., Jepsen S.L
Comput Biol Med
[DOI] [PMC free article] [PubMed] [Google Scholar] 261.Born J.M., Lemmens S.G.T., Rutters F., Nieuwenhuizen A.G., Formisano E., Goebel R., Westerterp-Plantenga M.S
There are no FDA-approved drugs for prediabetes, although metformin is recommended by the American Diabetes Association for this purpose
